NLRP3 and Parkinson disease: Consistently, inhibiting NLRP3 function with MCC950 evoked substantial neuroprotection in the 6-OHDA PD-model rats [387] and in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)-induced PD-model mice [384].